Today
+12.64%
5 Days
+13.36%
1 Month
+20.67%
6 Months
+41.92%
Year to Date
+84.71%
1 Year
+110.50%
• Product safety concerns and regulatory scrutiny impact share price. • Challenges in China and Japan markets affect international growth. • Institutional investors reduced stakes, contributing to price decline.
• CVS Health stock rose with strong earnings outlook and analyst support. • Favorable Medicare Advantage payment rates aid Aetna's earnings backdrop. • FTC insulin pricing settlement reduces regulatory uncertainty.
Centene (CNC) Q3 2026 Earnings Call: EPS Outlook Raised Above $5.20


| Shareholders | Proportion |
|---|---|
| AQR Capital Management, LLC | 6.44% |
| Vanguard Capital Management, LLC | 6.33% |
| BlackRock Institutional Trust Company, N.A. | 5.31% |
| Vanguard Portfolio Management, LLC | 4.38% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 42.40% |
| Investment Advisor/Hedge Fund | 34.39% |
| Hedge Fund | 11.71% |
| Research Firm | 3.76% |
Related Instruments